Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
DOJ scraps divisive China Initiative that swept up prominent scientists — but vows to keep guarding against ...
4 years ago
People
China
'F--- the feds': Martin Shkreli barred from running all public companies as judge decries remorseless behavior
4 years ago
Pharma
Tillman Gerngross makes it official: He's out as CEO as troubled Adagio vows to soldier on
4 years ago
People
R&D
With a new startup, ARCH and Takeda wade into growing search for a Swiss Army knife RNA drug
4 years ago
Financing
Startups
Unidentified witnesses accuse Bristol Myers of scuttling timely FDA move on liso-cel to avoid $6.4B payout
4 years ago
Pharma
Spectrum's penny stock takes another hit as CFO quietly plans exit
4 years ago
People
Pharma
Moderna ties the knot with Thermo Fisher on a 15-year manufacturing alliance, gluing a global network
4 years ago
Manufacturing
Building on CRISPR success, Intellia inks deal for new manufacturing facility in Waltham, MA
4 years ago
Pharma
Cell/Gene Tx
Akebia scrapes together $85M war chest to commercialize vada as PDUFA date looms
4 years ago
Financing
Pharma
AbbVie sees a megablockbuster in Vraylar. Could a new depression indication push peak sales past $4B?
4 years ago
Pharma
Pharma sustainability: Amgen debuts $750M ‘green bond,’ Merck initiates ESG goal review
4 years ago
Pharma
Marketing
FDA+ roundup: Assessor finds FDA's new biosimilar review model makes the process more predictable
4 years ago
FDA+
Bayer oncology vet Robert LaCaze has his eyes on next steps — landing his first gig as CEO of Sadelain co-founded ...
4 years ago
People
R&D
With Spark safely tucked into Roche, its founding CEO is off to search for new adventures
4 years ago
People
Cell/Gene Tx
Manufacturing reorg at Merck KGaA inspires a $500M+ investment in mRNA tech
4 years ago
Pharma
Manufacturing
Kiniksa inks licensing deal to take a Regeneron castoff into Asian markets
4 years ago
Deals
mRNA for all: WHO establishes biomanufacturing training hub in Korea
4 years ago
Coronavirus
Manufacturing
SoftBank, RA keep pumping money into biotech startups as protein degradation player bags $102M
4 years ago
Financing
Sanofi, GSK prep regulatory filings for Covid-19 vaccine after posting PhIII, booster data — but who will use it?
4 years ago
R&D
Coronavirus
Kodiak’s Eylea contender falls flat in PhIII, wiping out nearly $2B in value
4 years ago
R&D
Covid-19 roundup: Africa CDC to seek vaccine donation pause — report; New study suggests blood clots from ...
4 years ago
Coronavirus
Almost 9 in 10 Americans want the FDA to explain why some drugs are rejected, new JAMA survey finds
4 years ago
FDA+
They made the first anti-VEGF drug 20+ years ago. Now two longtime partners have $65M to spot new eye drugs
4 years ago
Financing
Startups
AstraZeneca's Pascal Soriot brought home nearly $19M last year, dwarfing some of Europe's highest pharma pay packages
4 years ago
Pharma
First page
Previous page
569
570
571
572
573
574
575
Next page
Last page